Yao Liu

8PUBLICATIONS
13CO-AUTHORS
Traditional Chinese medicine and treatmentsMedical biochemistry - amino acids and metabolitesClinical pharmacology and therapeuticsPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 29, 2025
Neuroprotective effects of Yangming-Kaixin-Yizhi formula in Alzheimer's disease: dual regulation of PI3K/Akt and p38 MAPK signaling via network pharmacology and experimental approaches.

Jing Lei, Jiaming Li, Wei Wu

|Apr 30, 2025
Neurological adverse events associated with baclofen: A disproportionality analysis based on FDA Adverse Event Reporting System.

Ni Zhang, Tingting Jiang, Yanping Li

|Jan 17, 2025
Integrating network pharmacology and experimental verification to reveal the ferroptosis-associated mechanism of Changpu-Yizhi-Wan in the treatment of Alzheimer's disease.

Rui Xiong, Hengxu Liu, Shipeng Zhang

|Jan 13, 2025
Unveiling unexpected adverse events: post-marketing safety surveillance of gilteritinib and midostaurin from the FDA Adverse Event Reporting database.

Tingting Jiang, Yanping Li, Ni Zhang

|Nov 25, 2024
First-Line Camrelizumab Plus Rivoceranib in Advanced Hepatocellular Carcinoma: A China-Based Cost-Effectiveness Analysis.

Guiyuan Xiang, Yueyue Huang, Ni Zhang

|Jan 31, 2024
Drug-induced interstitial lung disease: a real-world pharmacovigilance study of the FDA Adverse Event Reporting System from 2004 to 2021.

Tingting Jiang, Hui Su, Jing Xu

Pageof 2

Frequent Collaborators

2 joint publications

Ni Zhang

2 joint publications

Rui Xiong

1 joint publications

Hengxu Liu

1 joint publications

Shipeng Zhang